✦ LIBER ✦

T1211 Safety and Tolerability of Twice-Daily Balsalazide Tablets: Results from 2 Randomized, Double-Blind, Multicenter, Phase 3 Studies and 1 Open-Label, Multicenter, Phase 3 Study

✍ Scribed by Pruitt, Ron E.; Rosen, Alana A.; Wruble, Lawrence D.; Sedghi, Shahriar; Shepard, Roland D.; Mareya, Shadreck M.; Huang, Shirley; Shaw, Audrey L.; Forbes, William P.

Book ID: 122968946
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 105 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)62406-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1148 Safety and Tolerability of Twice-D

T1148 Safety and Tolerability of Twice-Daily Balsalazide Tablets: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

✍ Pruitt, Ronald E.; Rosen, Alan A.; Wruble, Lawrence; Sedghi, Shahriar; Shepard, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

T1147 Twice-Daily Balsalazide Tablets Im

T1147 Twice-Daily Balsalazide Tablets Improve Patient Quality of Life After 2 and 8 Weeks of Treatment: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

✍ Rubin, David T.; Rosen, Alan A.; Sedghi, Shahriar; Shepard, Roland D.; Mareya, S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

T1209 Twice-Daily Balsalazide Tablets Im

T1209 Twice-Daily Balsalazide Tablets Improve Patient Quality of Life After 2, 6, or 8 Weeks of Treatment: Results of Two Phase 3, Randomized, Double-Blind Multicenter Studies

✍ Rosen, Alana A.; Sedghi, Shahriar; Shepard, Roland D.; Mareya, Shadreck M.; Huan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Safety and Efficacy of Once-Daily Hydrom

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study

✍ Yu, Shiying; Shen, Wei; Yu, Lu; Hou, Yanyan; Han, John; Richards, Henry M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 518 KB

Once-Daily Gastroretentive Gabapentin fo

Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies

✍ Rauck, Richard L.; Irving, Gordon A.; Wallace, Mark S.; Vanhove, Geertrui F.; Sw 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 684 KB

A 2-year phase 3 study of safety and eff

A 2-year phase 3 study of safety and efficacy of etanercept 50 mg twice weekly in patients with psoriasis: Results from the 3-month double-blind period

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB